204 related articles for article (PubMed ID: 17611561)
21. HS1 protein is differentially expressed in chronic lymphocytic leukemia patient subsets with good or poor prognoses.
Scielzo C; Ghia P; Conti A; Bachi A; Guida G; Geuna M; Alessio M; Caligaris-Cappio F
J Clin Invest; 2005 Jun; 115(6):1644-50. PubMed ID: 15931393
[TBL] [Abstract][Full Text] [Related]
22. p65 activity and ZAP-70 status predict the sensitivity of chronic lymphocytic leukemia cells to the selective IkappaB kinase inhibitor BMS-345541.
López-Guerra M; Roué G; Pérez-Galán P; Alonso R; Villamor N; Montserrat E; Campo E; Colomer D
Clin Cancer Res; 2009 Apr; 15(8):2767-76. PubMed ID: 19351760
[TBL] [Abstract][Full Text] [Related]
23. Integrated genomic profiling of chronic lymphocytic leukemia identifies subtypes of deletion 13q14.
Ouillette P; Erba H; Kujawski L; Kaminski M; Shedden K; Malek SN
Cancer Res; 2008 Feb; 68(4):1012-21. PubMed ID: 18281475
[TBL] [Abstract][Full Text] [Related]
24. Defining the prognosis of early stage chronic lymphocytic leukaemia patients.
Pepper C; Majid A; Lin TT; Hewamana S; Pratt G; Walewska R; Gesk S; Siebert R; Wagner S; Kennedy B; Miall F; Davis ZA; Tracy I; Gardiner AC; Brennan P; Hills RK; Dyer MJ; Oscier D; Fegan C
Br J Haematol; 2012 Feb; 156(4):499-507. PubMed ID: 22171799
[TBL] [Abstract][Full Text] [Related]
25. Highly purified CD38+ and CD38- sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin.
Pepper C; Ward R; Lin TT; Brennan P; Starczynski J; Musson M; Rowntree C; Bentley P; Mills K; Pratt G; Fegan C
Leukemia; 2007 Apr; 21(4):687-96. PubMed ID: 17287849
[TBL] [Abstract][Full Text] [Related]
26. IGHV3-21 gene usage is associated with high TCL1 expression in chronic lymphocytic leukemia.
Mansouri MR; Sevov M; Aleskog A; Jondal M; Merup M; Sundström C; Osorio L; Rosenquist R
Eur J Haematol; 2010 Feb; 84(2):109-16. PubMed ID: 19889012
[TBL] [Abstract][Full Text] [Related]
27. Role of the RANKL/RANK system in the induction of interleukin-8 (IL-8) in B chronic lymphocytic leukemia (B-CLL) cells.
Secchiero P; Corallini F; Barbarotto E; Melloni E; di Iasio MG; Tiribelli M; Zauli G
J Cell Physiol; 2006 Apr; 207(1):158-64. PubMed ID: 16270354
[TBL] [Abstract][Full Text] [Related]
28. Identification of gene expression signatures for molecular classification in human leukemia cells.
Song JH; Kim HJ; Lee CH; Kim SJ; Hwang SY; Kim TS
Int J Oncol; 2006 Jul; 29(1):57-64. PubMed ID: 16773185
[TBL] [Abstract][Full Text] [Related]
29. B-chronic lymphocytic leukemia cells contain both endogenous kappa immunoglobulin mRNA and critical immunoglobulin gene activation transcription factors.
Zaknoen SL; Christian SL; Suen R; Van Ness B; Kay NE
Leukemia; 1992 Jul; 6(7):675-9. PubMed ID: 1625486
[TBL] [Abstract][Full Text] [Related]
30. PTPROt-mediated regulation of p53/Foxm1 suppresses leukemic phenotype in a CLL mouse model.
Motiwala T; Kutay H; Zanesi N; Frissora FW; Mo X; Muthusamy N; Jacob ST
Leukemia; 2015 Jun; 29(6):1350-9. PubMed ID: 25482129
[TBL] [Abstract][Full Text] [Related]
31. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
Klobusická M; Kusenda J; Babusíková O
Neoplasma; 2002; 49(6):387-93. PubMed ID: 12584586
[TBL] [Abstract][Full Text] [Related]
32. Dendrimer-based nanoparticles for potential personalized therapy in chronic lymphocytic leukemia: Targeting the BCR-signaling pathway.
Franiak-Pietryga I; Maciejewski H; Ostrowska K; Appelhans D; Voit B; Misiewicz M; Kowalczyk P; Bryszewska M; Borowiec M
Int J Biol Macromol; 2016 Jul; 88():156-61. PubMed ID: 26987432
[TBL] [Abstract][Full Text] [Related]
33. Genetic lesions in chronic lymphocytic leukemia: clinical implications.
Montserrat E; Moreno C
Curr Opin Oncol; 2009 Nov; 21(6):609-14. PubMed ID: 19713841
[TBL] [Abstract][Full Text] [Related]
34. The regulatory interaction of EVI1 with the TCL1A oncogene impacts cell survival and clinical outcome in CLL.
Vasyutina E; Boucas JM; Bloehdorn J; Aszyk C; Crispatzu G; Stiefelhagen M; Breuer A; Mayer P; Lengerke C; Döhner H; Beutner D; Rosenwald A; Stilgenbauer S; Hallek M; Benner A; Herling M
Leukemia; 2015 Oct; 29(10):2003-14. PubMed ID: 25936528
[TBL] [Abstract][Full Text] [Related]
35. Protein kinase D-dependent CXCR4 down-regulation upon BCR triggering is linked to lymphadenopathy in chronic lymphocytic leukaemia.
Saint-Georges S; Quettier M; Bouyaba M; Le Coquil S; Laurienté V; Guittat L; Lévy V; Ajchenbaum-Cymbalista F; Varin-Blank N; Le Roy C; Ledoux D
Oncotarget; 2016 Jul; 7(27):41031-41046. PubMed ID: 27127886
[TBL] [Abstract][Full Text] [Related]
36. miR-29 modulates CD40 signaling in chronic lymphocytic leukemia by targeting TRAF4: an axis affected by BCR inhibitors.
Sharma S; Pavlasova GM; Seda V; Cerna KA; Vojackova E; Filip D; Ondrisova L; Sandova V; Kostalova L; Zeni PF; Borsky M; Oppelt J; Liskova K; Kren L; Janikova A; Pospisilova S; Fernandes SM; Shehata M; Rassenti LZ; Jaeger U; Doubek M; Davids MS; Brown JR; Mayer J; Kipps TJ; Mraz M
Blood; 2021 May; 137(18):2481-2494. PubMed ID: 33171493
[TBL] [Abstract][Full Text] [Related]
37. Sprouty 2: a novel attenuator of B-cell receptor and MAPK-Erk signaling in CLL.
Shukla A; Rai K; Shukla V; Chaturvedi NK; Bociek RG; Pirruccello SJ; Band H; Lu R; Joshi SS
Blood; 2016 May; 127(19):2310-21. PubMed ID: 26809508
[TBL] [Abstract][Full Text] [Related]
38. The novel antisense Bcl-2 inhibitor SPC2996 causes rapid leukemic cell clearance and immune activation in chronic lymphocytic leukemia.
Dürig J; Dührsen U; Klein-Hitpass L; Worm J; Hansen JB; Ørum H; Wissenbach M
Leukemia; 2011 Apr; 25(4):638-47. PubMed ID: 21358717
[TBL] [Abstract][Full Text] [Related]
39. The Expression of Toll-Like Receptors in Patients with B-Cell Chronic Lymphocytic Leukemia.
Rybka J; Butrym A; Wróbel T; Jaźwiec B; Bogucka-Fedorczuk A; Poręba R; Kuliczkowski K
Arch Immunol Ther Exp (Warsz); 2016 Dec; 64(Suppl 1):147-150. PubMed ID: 28083607
[TBL] [Abstract][Full Text] [Related]
40. Variability in the degree of expression of phosphorylated IkappaBalpha in chronic lymphocytic leukemia cases with nodal involvement.
Rodríguez A; Martínez N; Camacho FI; Ruíz-Ballesteros E; Algara P; García JF; Menárguez J; Alvaro T; Fresno MF; Solano F; Mollejo M; Martin C; Piris MA
Clin Cancer Res; 2004 Oct; 10(20):6796-806. PubMed ID: 15501956
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]